Home KSQ Therapeutics

KSQ Therapeutics

In operation
Series C
Pharmaceutical R&D Developer

Basic Information

KSQ Therapeutics Offers a Novel R&D Approach, Where Much of the Risk-Reduction Work is Completed Before Candidate Therapeutics are Generated. Powered by its Proprietary CRISPRomics™ Drug Discovery Engine, the Company’s Team Elucidates the Role of Every Human Gene in Various Diseases, Providing a Unique and More Comprehensive Understanding of Disease Biology.
KSQ Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2015
info@ksqtx.com